Jasper Therapeutics Stock In The News
| JSPR Stock | USD 22.31 0.09 0.40% |
Our overall analysis of Jasper Therapeutics' news coverage and content from conventional and social sources shows investors' bearish mood towards Jasper Therapeutics. The specific impact of Jasper Therapeutics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Jasper Therapeutics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Jasper Therapeutics headlines in addition to utilizing other, more conventional financial analysis modules. Check out Jasper Therapeutics Backtesting and Jasper Therapeutics Hype Analysis. To learn how to invest in Jasper Stock, please use our How to Invest in Jasper Therapeutics guide.
Jasper |
Jasper Therapeutics Today Top News and Investor Outlook
Jasper Therapeutics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Jasper and other traded companies coverage with news coverage. We help investors stay connected with Jasper headlines for the 11th of December 2024 to make an informed investment decision based on correlating the impacts of news items on Jasper Stock performance. Please note that trading solely based on the Jasper Therapeutics hype is not for everyone as timely availability and quick action are needed to avoid losses.
Jasper Therapeutics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Jasper earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Jasper Therapeutics that are available to investors today. That information is available publicly through Jasper media outlets and privately through word of mouth or via Jasper internal channels. However, regardless of the origin, that massive amount of Jasper data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jasper Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jasper Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jasper Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jasper Therapeutics alpha.
Jasper Largest EPS Surprises
Earnings surprises can significantly impact Jasper Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-09 | 2024-06-30 | -1.09 | -0.97 | 0.12 | 11 | ||
2024-11-07 | 2024-09-30 | -1.07 | -1.24 | -0.17 | 15 | ||
2024-05-14 | 2024-03-31 | -1.23 | -1.03 | 0.2 | 16 | ||
2022-05-12 | 2022-03-31 | -0.35 | -0.06 | 0.29 | 82 | ||
2021-11-12 | 2021-09-30 | -0.28 | -0.69 | -0.41 | 146 | ||
2022-03-18 | 2021-12-31 | -0.34 | -0.79 | -0.45 | 132 |
Jasper Therapeutics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Jasper Therapeutics Stock. Current markets are slightly bearish. About 55% of major world exchanges and indexes are down. See today's market update for more information.
2nd of December 2024
Jasper Therapeutics Announces First Patient Dosed in Phase 1b2a ETESIAN Clinical Study of ... at finance.yahoo.com
29th of November 2024
Braidwell LP Takes 9.09 Million Position in Jasper Therapeutics, Inc. at thelincolnianonline.com
13th of November 2024
Jasper Therapeutics to Participate at Upcoming Investor Conferences at globenewswire.com
8th of November 2024
Velan Capital Investment Management LP Increases Stake in Outlook Therapeutics Inc at gurufocus.com
24th of October 2024
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of All... at globenewswire.com
15th of October 2024
Jasper Therapeutics Market Outperform Rating Reiterated at JMP Securities at thelincolnianonline.com
14th of October 2024
Jasper gains 11 percent on data for briquilimab in urticaria at seekingalpha.com
23rd of September 2024
Jasper Therapeutics, Inc. Given Average Recommendation of Buy by Brokerages - MarketBeat at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Jasper Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Jasper Therapeutics' short interest history, or implied volatility extrapolated from Jasper Therapeutics options trading.
Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.